Organization Profile

You just read:

Aeterna Zentaris Announces Top-Line Data from the Perifosine Phase 3 Trial in Refractory Advanced Colorectal Cancer

News provided by

Aeterna Zentaris Inc.

Apr 02, 2012, 07:03 ET